Filing Details

Accession Number:
0001850902-22-000027
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-02 16:34:32
Reporting Period:
2022-09-01
Accepted Time:
2022-09-02 16:34:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1850902 Alpha Teknova Inc. TKNO In Vitro & In Vivo Diagnostic Substances (2835) 943368109
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1861091 Matthew Lowell C/O Alpha Teknova, Inc.
2451 Bert Drive
Hollister CA 95023
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-09-01 10,000 $4.61 20,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $4.32 to $4.88, inclusive. The reporting person undertakes to provide to Alpha Teknova, Inc. (the Company), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this Footnote 1.